Consistent dosing-time dependent tolerability of everolimus (EV) in a pilot study in women with metastatic breast cancers (MBC) and in a mouse chronopharmacology investigation
Yazar
Espie, M.
Okyar, Alper
Arrondeau, J.
Chang-Marchand, Y.
Levi, F.
Giacchetti, S.
Li, X. M.
Ozturk, N.
Cuvier, C.
Machowiak, J.
Üst veri
Tüm öğe kaydını gösterBağlantı
http://hdl.handle.net/20.500.12627/142966https://doi.org/10.1158/1538-7445.sabcs16-p4-06-06
Koleksiyonlar
- Bildiri [64839]